Cell kinetics of mouse tumour subjected to photodynamic therapy - Evaluation by proliferating cell nuclear antigen immunohistochemistry

Oral Oncology

Volumn 35, Issue 1, 1999, Pages 93-97

  Uehara, M ^a   Inokuchi, T ^a   Sano, K ^a   Sekine, J ^a   Ikeda, H ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cell proliferative activity; Fractionation interval; Immunohistochemistry; Photodynamic therapy; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL DESTRUCTION; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUTH TUMOR; NEODYMIUM LASER; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C3H; NECROSIS; NEOPLASM PROTEINS; PHOTOCHEMOTHERAPY; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0032889736     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00073-6     Document Type: Article

References (20)

1. Pe M.B., Ikeda H., Inokuchi T. Tumour destruction and proliferation kinetics following periodic, low power light, haematoporphyrin oligomers mediated photodynamic therapy in the mouse tongue. Oral Oncology, European Journal of Cancer. 30B:1994;174-178.
2. Uehara M., Inokuchi T., Sano K. Experimental study of combined hyperthermic and photodynamic therapy on carcinoma in the mouse. Journal of Oral and Maxillofacial Surgery. 54:1996;729-736.
3. Uehara M., Inokuchi T., Sano K., Pe M.B. The anti-tumor effect of photodynamic therapy evaluated by bromodeoxyuridine immunohistochemistry. International Journal of Oral and Maxillofacial Surgery. 27:1998;204-208.
4. Usui S., Urano M., Koike S., Kobayashi Y. Effect of PS-K, a protein polysaccharide, on pulmonary metastases of a C3H mouse squamous cell carcinoma. Journal of the National Cancer Institute. 56:1976;185-187.
5. Miyoshi N., Hirata A., Kunimi K., et al. Spectroscopic study of haematoporphyrin oligomers in tumor tissue. Lasers in Medical Science. 3:1988;185-193.
6. Morris G.F., Mathews M.B. Regulation of proliferation cell nuclear antigen during the cell cycle. Journal of Cell Biology. 264:1989;13 856-13 864.
7. Celis J.E., Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proceedings of the National Academy of Science USA. 82:1985;3262-3266.
8. Fingar V.H., Henderson B.W. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochemistry & Photobiology. 46:1987;837-841.
9. Moan J., Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Research. 45:1985;1608-1610.
10. Korbelik M., Krosl G. Cellular levels of photosensitisers in tumors: the role of proximity to the blood supply. British Journal of Cancer. 70:1994;604-614.
11. Shivji M.K.K., Kenny M.K., Wood R.D. Proliferating cell nuclear antigen is required for DNA excision repair. Cell. 69:1992;367-374.
12. He X.Y., Sikes R.A., Thomsen S., Chung L.W.K., Jacques S.L. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines. Photochemistry & Photobiology. 59:1994;468-473.
13. Moan J., Waksvik H., Christensen T. DNA single-strand breaks and sister chromatid exchanges induced by treatment with hematoporphyrin and light or by X-rays in human NHIK 3025 cells. Cancer Research. 40:1980;2915-2918.
14. Foster T.H., Murant R.S., Bryant R.G., Knox R.S., Gibson S.L., Hilf R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiation Research. 126:1991;296-303.
15. Messmann H., Mlkvy P., Buonaccorsi G., Davies C.L., MacRobert A.J., Bown S.G. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. British Journal of Cancer. 72:1995;589-594.
16. van der Veen N., van Leengoed H.L.L.M., Star W.M. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. British Journal of Cancer. 70:1994;867-872.
17. Gibson S.L., VanDerMeid K.R., Murant R.S., Raubertas R.F., Hilf R. Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas. Cancer Research. 50:1990;7236-7241.
18. Henderson B.W., Fingar V.H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Research. 47:1987;3110-3114.
19. Nelson J.S., Liaw L.H., Berns M.W. Tumor destruction in photodynamic therapy. Photochemistry & Photobiology. 46:1987;829-835.
20. 14C]- hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Research. 39:1979;146-151.